Literature DB >> 23136658

Treatments: In the waiting room.

Michael Eisenstein.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23136658     DOI: 10.1038/491s14a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Improved social and language skills after secretin administration in patients with autistic spectrum disorders.

Authors:  K Horvath; G Stefanatos; K N Sokolski; R Wachtel; L Nabors; J T Tildon
Journal:  J Assoc Acad Minor Phys       Date:  1998

2.  Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

Authors:  Sébastien Jacquemont; Aurore Curie; Vincent des Portes; Maria Giulia Torrioli; Elizabeth Berry-Kravis; Randi J Hagerman; Feliciano J Ramos; Kim Cornish; Yunsheng He; Charles Paulding; Giovanni Neri; Fei Chen; Nouchine Hadjikhani; Danielle Martinet; Joanne Meyer; Jacques S Beckmann; Karine Delange; Amandine Brun; Gerald Bussy; Fabrizio Gasparini; Talita Hilse; Annette Floesser; Janice Branson; Graeme Bilbe; Donald Johns; Baltazar Gomez-Mancilla
Journal:  Sci Transl Med       Date:  2011-01-05       Impact factor: 17.956

3.  A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Authors:  Antonio Y Hardan; Lawrence K Fung; Robin A Libove; Tetyana V Obukhanych; Surekha Nair; Leonore A Herzenberg; Thomas W Frazier; Rabindra Tirouvanziam
Journal:  Biol Psychiatry       Date:  2012-02-18       Impact factor: 13.382

4.  Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.

Authors:  Robert W Summers; David E Elliott; Khurram Qadir; Joseph F Urban; Robin Thompson; Joel V Weinstock
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

5.  Correction of fragile X syndrome in mice.

Authors:  Gül Dölen; Emily Osterweil; B S Shankaranarayana Rao; Gordon B Smith; Benjamin D Auerbach; Sumantra Chattarji; Mark F Bear
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

6.  Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

Authors:  Aubin Michalon; Michael Sidorov; Theresa M Ballard; Laurence Ozmen; Will Spooren; Joseph G Wettstein; Georg Jaeschke; Mark F Bear; Lothar Lindemann
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.